171 related articles for article (PubMed ID: 32045628)
1. The Role of Glutamate Neurotransmission in Mismatch Negativity (MMN), A Measure of Auditory Synaptic Plasticity and Change-detection.
Harms L; Parras GG; Michie PT; Malmierca MS
Neuroscience; 2021 Feb; 456():106-113. PubMed ID: 32045628
[TBL] [Abstract][Full Text] [Related]
2. Mismatch negativity indexes illness-specific impairments of cortical plasticity in schizophrenia: a comparison with bipolar disorder and Alzheimer's disease.
Baldeweg T; Hirsch SR
Int J Psychophysiol; 2015 Feb; 95(2):145-55. PubMed ID: 24681247
[TBL] [Abstract][Full Text] [Related]
3. A predictive coding account of MMN reduction in schizophrenia.
Wacongne C
Biol Psychol; 2016 Apr; 116():68-74. PubMed ID: 26582536
[TBL] [Abstract][Full Text] [Related]
4. Frontal Glutamate and γ-Aminobutyric Acid Levels and Their Associations With Mismatch Negativity and Digit Sequencing Task Performance in Schizophrenia.
Rowland LM; Summerfelt A; Wijtenburg SA; Du X; Chiappelli JJ; Krishna N; West J; Muellerklein F; Kochunov P; Hong LE
JAMA Psychiatry; 2016 Feb; 73(2):166-74. PubMed ID: 26720179
[TBL] [Abstract][Full Text] [Related]
5. Resting-state glutamatergic neurotransmission is related to the peak latency of the auditory mismatch negativity (MMN) for duration deviants: An (1)H-MRS-EEG study.
Kompus K; Westerhausen R; Craven AR; Kreegipuu K; Põldver N; Passow S; Specht K; Hugdahl K; Näätänen R
Psychophysiology; 2015 Sep; 52(9):1131-9. PubMed ID: 25917405
[TBL] [Abstract][Full Text] [Related]
6. Schizotypy and auditory mismatch negativity in a non-clinical sample of young adults.
Broyd SJ; Michie PT; Bruggemann J; van Hell HH; Greenwood LM; Croft RJ; Todd J; Lenroot R; Solowij N
Psychiatry Res Neuroimaging; 2016 Aug; 254():83-91. PubMed ID: 27388803
[TBL] [Abstract][Full Text] [Related]
7. Late deviance detection in rats is reduced, while early deviance detection is augmented by the NMDA receptor antagonist MK-801.
Harms L; Fulham WR; Todd J; Meehan C; Schall U; Hodgson DM; Michie PT
Schizophr Res; 2018 Jan; 191():43-50. PubMed ID: 28385587
[TBL] [Abstract][Full Text] [Related]
8. A neuronal model of predictive coding accounting for the mismatch negativity.
Wacongne C; Changeux JP; Dehaene S
J Neurosci; 2012 Mar; 32(11):3665-78. PubMed ID: 22423089
[TBL] [Abstract][Full Text] [Related]
9. Effects of NMDA receptor antagonist memantine on mismatch negativity.
Korostenskaja M; Nikulin VV; Kicić D; Nikulina AV; Kähkönen S
Brain Res Bull; 2007 May; 72(4-6):275-83. PubMed ID: 17452287
[TBL] [Abstract][Full Text] [Related]
10. Acute dopamine D(1) and D(2) receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects.
Leung S; Croft RJ; Baldeweg T; Nathan PJ
Psychopharmacology (Berl); 2007 Nov; 194(4):443-51. PubMed ID: 17611739
[TBL] [Abstract][Full Text] [Related]
11. Synaptic interactions and inhibitory regulation in auditory cortex.
Askew CE; Metherate R
Biol Psychol; 2016 Apr; 116():4-9. PubMed ID: 26555718
[TBL] [Abstract][Full Text] [Related]
12. Parsing components of auditory predictive coding in schizophrenia using a roving standard mismatch negativity paradigm.
McCleery A; Mathalon DH; Wynn JK; Roach BJ; Hellemann GS; Marder SR; Green MF
Psychol Med; 2019 May; 49(7):1195-1206. PubMed ID: 30642411
[TBL] [Abstract][Full Text] [Related]
13. Chronic effects of cannabis use on the auditory mismatch negativity.
Greenwood LM; Broyd SJ; Croft R; Todd J; Michie PT; Johnstone S; Murray R; Solowij N
Biol Psychiatry; 2014 Mar; 75(6):449-58. PubMed ID: 23830666
[TBL] [Abstract][Full Text] [Related]
14. Impaired mismatch negativity (MMN) generation in schizophrenia as a function of stimulus deviance, probability, and interstimulus/interdeviant interval.
Javitt DC; Grochowski S; Shelley AM; Ritter W
Electroencephalogr Clin Neurophysiol; 1998 Mar; 108(2):143-53. PubMed ID: 9566627
[TBL] [Abstract][Full Text] [Related]
15. The effects of ketamine on the mismatch negativity (MMN) in humans - A meta-analysis.
Rosburg T; Kreitschmann-Andermahr I
Clin Neurophysiol; 2016 Feb; 127(2):1387-1394. PubMed ID: 26699665
[TBL] [Abstract][Full Text] [Related]
16. Mismatch-negativity (MMN) in animal models: Homology of human MMN?
Shiramatsu TI; Takahashi H
Hear Res; 2021 Jan; 399():107936. PubMed ID: 32197715
[TBL] [Abstract][Full Text] [Related]
17. Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia.
Javitt DC; Steinschneider M; Schroeder CE; Arezzo JC
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11962-7. PubMed ID: 8876245
[TBL] [Abstract][Full Text] [Related]
18. NMDA Receptor Antagonist Effects on Speech-Related Mismatch Negativity and Its Underlying Oscillatory and Source Activity in Healthy Humans.
de la Salle S; Shah D; Choueiry J; Bowers H; McIntosh J; Ilivitsky V; Knott V
Front Pharmacol; 2019; 10():455. PubMed ID: 31139075
[TBL] [Abstract][Full Text] [Related]
19. The effect of N-methyl-D-aspartate receptor antagonists on the mismatch negativity of event-related potentials and its regulatory factors: A systematic review and meta-analysis.
Guo X; Yu J; Quan C; Xiao J; Wang J; Zhang B; Hao X; Wu X; Liang J
J Psychiatr Res; 2024 Apr; 172():210-220. PubMed ID: 38402843
[TBL] [Abstract][Full Text] [Related]
20. Acute high-dose glycine attenuates mismatch negativity (MMN) in healthy human controls.
Leung S; Croft RJ; O'Neill BV; Nathan PJ
Psychopharmacology (Berl); 2008 Feb; 196(3):451-60. PubMed ID: 17952411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
